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In a recent review, Volkert and Lundstedt have discussed the available data which 
indicated the existence of an independent cell-mediated immunity to the LCM virus 
in mice  (1).  It was concluded that this immunity was provoked during the  acute 
phase of the infection and that it was probably the decisive factor for the outcome of 
the infection. During the next 2 yr other authors published experimental reports which 
supported this assumption. Tosolini and Minas employed the footpad test in acutely 
infected mice and were able to demonstrate the time-course of the development of a 
D-type hypersensibility  reaction (2). Moreover, the original work by Lundstedt which 
indicated a  cytotoxic effect  of  immune lymphocytes on LCM  virus-infected target 
cells  (3)  was confirmed by Holtermann and Majde (4).  Finally, Wright et al. have 
employed the Hellstrtim method in the same kind of experiments and have published 
data which might indicate that  the  cytotoxic effect  of  lymphocytes from  immune 
donors can be suppressed by different kinds of immunosuppressive treatments (5). 
In spite of the fact that all parties concerned seem to agree on the importance 
of the cell-mediated immunity to LCM virus, very little is as yet known about 
the mechanism involved in this immune reaction. The main reason for this is 
the lack of a  reliable and reproducible in vitro method for measuring the cell- 
mediated immunity provoked by an LCM  viral infection. A  method of  this 
type has been developed in our laboratory and it is the purpose of this paper 
to present the results obtained concerning the cell-mediated immunity to the 
LCM virus in mice. 
Materials and Methods 
Animals.--For virus titration purposes, ordinary Swiss mice weighing 12-14 g were used. 
For the experiments proper, strictly inbred C3H mice kept and bred in this laboratory were 
used throughout the study. 
Persistent  tolerant virus carriers (virus carriers) were produced by inoculating newborn 
mice within the first 18 h of life with approximately 103 LDs0 of the virus intraperitoneally 
(i.p.).  1 As previously described (6), this treatment results in a state of immunological toler- 
ance, and the mice will  carry virus in high titers in blood and organs throughout life. 
Virus.--The LCM virus strain used was originally obtained from Dr. Traub (Tiibingen, 
1 Abbreviations used in  this paper: CF,  complement fixation; CI,  cytotoxic index; FBS, 
foetal bovine serum; i.p., intraperitoneally;  MEM, minimal essential medium; PBS, phos- 
phate-buffered saline. 
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Germany). For infection of mice, a  virus suspension produced from virus carrier spleens was 
used. The spleens were  removed aseptically,  ground in a  mortar with sterile sea sand,  and 
suspended in 1 ml of phosphate-buffered saline (PBS) with 10% foetal bovine serum (FBS) and 
1% penicillin/streptomycin solution  (P/S)  per spleen. The virus preparation was kept in am- 
poules at --70°C, and its liter varied from 104..5 to 10 ~~ LD10/0.03 ml. 
For  infection of the L  cells, which served as  target cells in  tile cytotoxic reaction,  virus 
propagated  in  tissue culture was employed. For  this purpose monolayers of L  cells in  Roux 
bottles were infected in  the conventional manner for 60-90 rain,  After the infection, 40  ml 
of minimal essential medium (MEM) with 5% FBS and 3% bicarbonate was added, and 48 h 
later  the tissue culture medium was harvested. It was ampouled and stored at  --70°C;  the 
titer of this virus preparation ranged from 10 ~'~ to 107. 0 LDa0/0.03 ml. 
The  virus  titrations  were  all  carried  out  using intraeerebral  injections  of serial  10-fold 
dilutions  in ordinary  Swiss mice.  The  tilers  were  calculated  by  the  method of Kiirber  (7) 
and expressed as LD5o/0.03  ml. 
Complement  Fixation Test (CF Test).-Zrhe standard procedures used have been  described 
in a  previous paper  (8). The method was altered only in that Sever's microtechnique (9)  was 
employed. 
The Cylotoxlc Tesl.--The cytotoxic test is based on a combination of a  51Cr release method 
for  measuring cell-mediated  allograft  immunity in  vitro,  described  by Brunner et  al.  (10), 
and the HellstrSm test for lymphocyte-mediated cellular immunity (H). It was carried out as 
follow s: 
Lymphocyte  suspensions:  Spleen,  superficial  inguinal,  and  axillary  lymph  nodes  were 
removed aseptically,  cut into small pieces,  and pressed  through a  stainless steel mesh. This 
procedure and the following two washings were carried out in Hanks' balanced salt solution 
with 0.5'% lactalbumin. Finally,  the cells were resuspended in MEM with 15% FBS and 3% 
bicarbonate to a  concentration of 4.4 X  106 per ml. 
L cells:  3-5-day old monolayer cultures of L  cells were trypsinized and a  suspension con- 
taining 1.7  ;<  105 cells/ml was prepared in MEM with 0.5~7c FBS and 3~  bicarbonate. LCM 
virus to a  multiplicity of 10-40 LDs0 per L  cell was added and the cells were kept in suspen- 
sion for 90 min at 37°C, at which point MEM with 3.89~. FBS and 3% bicarbonate was added 
to give a final concentration of 0.16 )  106 L  cells/ml, and the infection was continued in sus- 
pension for further 20 h. Uninfected L  cells for controls were treated in exactly the same way 
except that medium was added instead of virus. 
Fluorescence staining:  The efl?ciency of  the infection of  the L  cells was checked by  the 
direct fluorescent antibody-staining technique, as described previously (12).  When the meth- 
ods described are used, about 90% of the cells are infected. 
Labeling:  On the day of the assay, infected and uninfected L  cells were counted and sus- 
pensions of each type of cells, containing 1 N  10 ~ cells/ml, were made up in MEM with 15% 
FBS and 3% bicarbonate.  After the adding of chromium-51 (as sodium chromate, ISOTOP 
service, Aktiebolaget Atomenergi, Sweden),  to give l0/~Ci/10 ~' L  cells, the cells were labeled 
at 37°C with magnetic stirring for 43 min. After two washings the cells were resuspended in 
MEM with I5% FBS and kept agitated at 37°C for 30 rain. ?filer another two washings and 
resuspension to a final concentration of 1.75 )<  10 ~ per ml, the cells were distributed in plastic 
Petri dishes (50 x  10 ram, A/S Nunc, Roskilde, Denmark), each dish receiving 4.0 ml of  the 
cell suspension. 
Tlw reaction  mixtures:  After  the  L  cells were plated  the Petri  dishes were  placed  hori- 
zontally at 37°C  in a  humid atmosphere containing 15-20% carbon dioxide for 60-120 rain. 
At this point 4  ml of the final lymphocyte suspension was added,  so that the ratio  between 
target  cells and  the lymphoeytes was  1:25,  and  the Petri  dishes were incubated under the 
conditions mentioned above. All the suspensions of lymphocytes assayed were tested at least 
in triplicate.  After  18 h, samples from each Petri  dish were centrifuged and 0.400 ml of the OLE  lV[ARKER AND  MOGENS  VOLKERT  1513 
supernatant was transferred to plastic counting vials. Scintillation liquid was added and the 
amount of  radioisotope  was  determined as  counts per minute in  a  Beckman  scintillation 
counter type LS-250 (Beckman Instruments, Inc., Fullerton, Calif.). 
The degree of  5~Cr release, and the target cell destruction, was expressed as a  cytotoxic 
index (CI) which reflects the ratio between the actual amounts of 51Cr released and the total 
amounts incorporated. The amounts of radioisotope were measured as counts per minute and 
for the calculation the following fraction was used (I0): 
(51Cr release in the presence of immune lymphoid cells) 
CI  =  --  (51Cr release in the presence of normal lymphoid cells) .  100. 
(Total ~lCr incorporated) 
--  (51Cr release in the presence of normal lymphocytes) 
Test for the Enhancing Antlbodies.--Blood from virus carriers and from normal mice was 
obtained by opening the thoracic cavity and cutting the vessels at the base of the heart in 
mice immediately after death from inhalation of chloroform. The blood was left overnight to 
coagulate and then centrifuged to obtain the serum. The serum was inactivated at 56°C  for 
30 rain. 
When the labeled L cells had fixed to the bottom of the Petri dishes the medium was dis- 
carded and 0.5 ml of the serum, diluted 1:6 in PBS pH 7, from either virus carriers or normal 
mice was added  to  the dishes. The cells were incubated at 37°C in a  COs atmosphere  and 
manually tilted every 5-10 rain for 45 rain. After the serum had been discarded, 4 ml of the 
lymphocyte suspension in MEM without FBS was added before incubation for another 45 
rain. Thereafter, 4 ml of MEM with 30c7o FBS was added to each dish, and the rest of the 
test was carried out as described above. 
RESULTS 
The Cell-Mediated Immunity during the Acute Infeclion.--The  time-course of 
the cell-mediated  immunity  provoked  by  the LCM  virus during  an  acute  in- 
fection  in  adult  mice  was  determined  in  four  experiments.  Each  of  these  ex- 
periments was designed as follows: 
Groups  of six mice were  inoculated i.p.  with  10 a LDs0 LCM virus at various intervals 
before the assay was performed. On the day of the experiment all the mice were killed and 
suspensions of pooled lymphocytes from each group of animals were prepared. The cytotoxic 
activity of all the cell suspensions was then tested simultaneously on target cells and in cul- 
ture media from the same batches. 
The results from one of these experiments are recorded in Fig.  1 and the data 
from all four experiments are summarized in Table I. It appears that the cyto- 
toxic activity is already detectable a  few days after infection. It then increases 
rapidly,  reaching a  maximum  on about  day  9,  and  thereafter declines equally 
steeply.  At  the end  of  the 2nd  wk  after infection  the cytotoxic  activity is al- 
ready  reduced  to  less  than  half of its previous  maximum.  During  the 3rd  wk 
the decline is more moderate, and hereafter  the cellular immunity is hardly de- 
tectable. 
As shown in Table I  the cell-mediated immunity  provoked during the acute 
LCM  virus infection follows  roughly  the same  course  in  all four  experiments. 1514  IMMUNITY  TO  LYMPHOCYTIC  CHORIOMENINGITIS  VIRUS 
In order to compare this cellular immunity with the humoral response to the 
virus, different groups of six to  eight adult mice were  tested individually for 
the  presence of  CF  antibodies at different times  after  the  inoculation of  10  3 
LDs0 LCM virus i.p. The data obtained are recorded in Fig. 2.  In agreement 
with  the  results presented previously by  other  workers  and  with  numerous 
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FIG. I.  The cell-mediated immune response to LCM virus in groups of normal adult C3H 
mice after intraperitoneal injection of 10 3  LDs0 of LCM virus on day 0. The magnitude of 
the response is expressed as the cytotoxic indices (CYT. IND.) of the lymphoid cells from the 
different groups of mice. 
TABLE I 
The Time-Course of the Cell-Mediated Immunity q/?er i.p, [noc~dation  of 1,000 LDso LCM  Virus 
CI on dayno. 
Exp.  no. 
O  2-3  5-6  9  12  15-16  18  21  24 
1  0  3  64  102  61  25  28  14 
2  0  10  39  99  38  43  31  24  16 
3  0  0  0  100  100  66  40  18 
4  0  0  0  76  45  6  0  0 
experimental data from this laboratory, it appears that the CF antibodies are 
produced slowly, and that  they do not reach  measurable titers before  day 9 
or I0 after the infection. From then on the titer rises steeply, reaching a maxi- 
mum at the end of the 2nd wk and then remaining constant for a  long time. 
The  development  of  antibodies  is  consequently greatly  delayed  compared 
with  the  cell-mediated immune reaction, and has  a  strikingly different time- 
course. 
In an attempt to correlate the viremia with the time-courses of the two differ- OLE  MARKER  AND  MOGENS  VOLKERT  1515 
ent kinds  of immune  response various  groups of six to eight adult  mice were 
also  tested  for blood virus  titers  at  different  times  after  the  i.p.  injection  of 
10  3 LDs0 LCM virus.  Several  experiments  of this kind  were carried  out.  The 
data obtained agree well with one another and the results from two experiments 
are shown in Figs. 2 and 3, which compare the blood virus titer with humoral 
and cellular immunity, respectively. It is evident that there is a close accordance 
between  the  graphs showing the cell-mediated  immunity and  the blood virus 
titers. However, as could be expected, in the period immediately after infection 
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Fro. 2.  Complement-fixing antibody titers  and blood virus  titers  in  normal  adult  C3H 
mice after intraperitoneal  injection of 10  3 LDs0 of LCM virus on day 0. Complement-fixing 
antibodies  (CF TITER) and blood virus titers  (VIRUS)  are mean titers of six mice tested 
with intervals throughout  the period of experimentation.  (NO TRACE: virus titer  _-< 10 °" ~.) 
the graph showing the time-course of the blood virus titer is 3-4 days ahead of 
that depicting the cell-mediated inununity, while both of them decline to very 
low levels at the same time. This is in contrast to the humoral immunity.  As 
can be seen  from Fig.  2,  the  CF  antibodies  are  just  reaching detectable  con- 
centrations when practically all the virus has disappeared from the blood. 
Cell-Mediated Immunity in Adoptively Immunized  Virus Carriers.--Volkert, 
Larsen,  and Pfau (8) have demonstrated that LCM virus carrier mice develop 
an unusually  strong humoral  immune  reaction  accompanied  by a  clearing  of 
the virus from the  blood and organs when  the  animals  are transplanted  with 
lymphoid cells  from immune  donors.  In view  of these  findings  it  seemed  in- 
teresting to determine the cell-mediated immunity during  adoptive  immuniza- 
tion of virus carrier mice. 1516  IMMUNITY  TO  LYMPHOCYTIC  CHORIOMENINGITIS VIRUS 
As donors were chosen female C3H mice which had been immunized to the virus by nursing 
infected babies 6-8 wk earlier. The cells for transplantation were harvested  from the spleens 
and lymph nodes. Because of the data obtained by Volkert and Larsen  (13), who showed that 
the maximal effect could  be obtained  by  transplanting cell  doses of about 100  X  106 cells 
and that the minimal effective dose was about 10-.20 X  106 immune cells,  these doses were 
chosen for our purpose. 100 X  106 cells were employed in three experiments, 20 >(  106 in two 
experiments, and 10 ;<  l0 s in one experiment. In order to ascertain the  cell-dose dependency 
of the cell-mediated immune response, doses of 100 and 10  X  106 were used in the same ex- 
periment. In all experiments groups of six virus carriers were transplanted intravenously at 
different times before the cytotoxicity experiment was carried out. On the day of the experi- 
ment the spleen and lymph node cells from each group of recipient mice were harvested and 
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FIG. 3.  Cell-mediated immunity and blood  virus  titers in normal adult  C3H  mice after 
intraperitoneal injection of  10  a LDs0  of  LCM  virus  on  day  0.  The  cell-mediated  immune 
response is expressed as the cytotoxic indices (CYT. IND.) of lymphoid cells from the different 
groups of mice. Blood virus titers (VIRUS) are mean titers of eight mice tested with intervals 
throughout the period of experimentation. (NO TRACE: virus titer =<  10 °' a.) 
tested separately for cytotoxicity on target cells from the same batch and in the same culture 
medium.  In  addition,  the blood was  tested for virus, and  the serum for complement-fixing 
antibodies. A pool of lymphoid cells  from normal adult mice infected with  10  a LD50 LCM 
virus 9 days earlier served as a positive control in all experiments. 
The results of the three experiments in which 100 X  106 cells had been trans- 
planted were very similar to one another (Table II). The data from one of them 
are  presented  graphically  in  Fig.  4.  It  appears  that  a  cell-mediated  immunity 
also  develops  in  adoptively  immunized  virus  carriers.  This  immunity  reaches 
its peak on day 9 and thereafter it declines quite rapidly. Thus this time-course 
is  similar  to  that  described  in  the  acutely  infected  mice.  It  is  vew  striking, OLE  MARKER  AND  MOGENS  VOLKERT  1517 
however,  that  the peak  value is considerably  lower  during  adoptive  immuni- 
zation.  In all the experiments in this series the  CIs were  below 45,  i.e.,  about 
half of  the  value  obtained  with control  cells  from  acutely  infected  mice.  The 
experiments in which 10 or 20  X  l06 immune  cells had been transplanted  were 
also  similar  to  one  another.  The  results  are  recorded  in  Fig.  4  and Table  II. 
TABLE  II 
The Time-Course of the Cell-Mediated Immunity in Virus Carriers after Intravenous 
Transplantation of Lymphoid Cells  from Immunized Syngeneic Mice 
Cell dose 
Cytotoxicity of lymphoid cells from recipients expressed as CI 
Days after transplantation 
0  2  5  9  12  19  30 
100  X  106  0  0  31  37  20  19  11 
100  X  106  0  0  0  31  11  6  12 
100  X  106*  0  40  9 
20  X  106  0  3  3  3  9  7  5 
20  X  106  0  0  0  10  14  0  4 
10  X  106*  0  13  5 
* These results were obtained in one experiment. 
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FIG. 4.  Complement-fixing antibody titers and cell-mediated immunity in virus carriers 
adoptively immunized with spleen and lymph node cells from immune syngeneic animals. 
The complement-fixing antibody titers (CF TITER) are determined on serum pools from six 
mice, which had received 100 X  106 sensitized cells on day 0. The cell-mediated immune re- 
sponse is expressed as cytotoxic indices of lymphoid cells from virus carriers, which received 
100 and 20 X  106 sensitized cells, respectively. Spleen and lymph node cells from normal adult 
C3H mice injected with 103 LDs0 of LCM virus 9 days earlier (AC. SENS. CELLS) served as 
positive controls in the cytotoxicity experiments. 1518  IMMUNITY TO  LYMPHOCYTIC CHORIOMENINGITIS VIRUS 
When  compared  with  the  results just  described it is apparent  that  the  cyto- 
toxic  activity  appeared  at  about  the  same  time  but  reached  lower  values. 
This  was  confirmed  by the  results  from  the  experiments in  which  the  trans- 
plantation  of  100  and  10  X  106  cells were  tested  simultaneously  (Table  II). 
Fig. 4  also shows the complement-fixing antibody titers obtained when  100  X 
10  ~ immune  lymphoid cells are  transplanted to virus carriers. The  results are 
in  complete agreement with  the results reported by Volkert and Larsen.  It is 
seen  that  the  titers obtained  are  about  100  times as high  as  those  seen  after 
an acute infection in normal mice. Moreover,  the peak titer is reached just as 
rapidly as was the case for the cell-mediated immunity. The virus blood titer 
graphs  are not  recorded.  In  all cases the  data obtained were  in  complete ac- 
cordance with the original findings of Volkert, Larsen, and Pfau  (8). The virus 
disappeared from the blood within  10 days of the transplantation, i.e., during 
the period in which the rise in both cellular and humoral immunity took place. 
The Search for Cell-Mediated Immunity and Enhancing  Antibodies  in  Virus 
Carrier Mice.--Most of  the  workers  concerned  agree  that  the  persistence  of 
high  titers of LCM  virus in  blood and  organs  in  mice infected in utero or at 
birth is due to a  state of tolerance to the virus. However, some doubt has also 
been expressed about the validity of this hypothesis and therefore experiments 
were carried out to investigate the possibility of the presence of cell-mediated 
immunity and of enhancing antibodies in these mice. 
In  the  first  group  of  experiments  the  cytotoxic activity of  lymphoid  cells 
from  virus  carriers  and  from  normal  mice  was  compared.  Three  experiments 
were  carried out.  In each  of these lymphoid cell suspensions from  the  spleen 
and  the  lymph  nodes  were  prepared  individually from  six virus  carriers and 
from six normal mice of the same strain, age, and  sex. These cell suspensions 
were tested separately but simultaneously on target cells from the same batch 
of infected L  cells and in  the  same culture  media.  The  results from  all three 
experiments agreed very closely and  the  data from one  of them  are recorded 
in Table III. It is apparent  that  the lymphocytes from  the virus carrier mice 
had no more cytolytic effect than cells from normal mice. Thus our experiments 
did not reveal any celt-mediated immunity to  the virus in LCM virus carrier 
mice. 
In  an  attempt  to  demonstrate  enhancing  antibodies in  LCM  virus  carrier 
mice,  pools  of  serum  were  prepared  from  three  groups  of  virus  carrier mice 
and from three groups of normal mice of the same strain, age, and sex. 
Each group of mice consisted of 15 animals.  On 3 different  days, one of the virus carrier 
serum pools was compared with a pool of normal serum. The technique employed is described 
above (Materials and Methods),  but it should be added that in all the experiments  10 or more 
Petri dishes with infected  target ceils were used per serum pool. The effector cells were in all 
cases spleen and lymph node cells from C3H  mice which had been infected  with the LCM 
virus 9 days previously. OLE  MARKER  AND  MOGENS  VOLKERT  1519 
The  results  from  these  experiments  are  recorded  in  Table  IV  and  clearly 
demonstrate  that  there  is  no  significant  difference  between  the  CIs  obtained 
after pretreatment  of the target cells with serum from normal  animals or from 
virus carriers. Thus no trace of enhancing antibodies was found  in virus  carrier 
serum. 
Dose Effect of Sensitized Lymphocyles.--It is  well known  that  a  stimulation 
of  sensitized lymphocytes  with  antigen  causes  release  of soluble factors  which 
TABLE  III 
The Release of Radioisotope from LCM Virus-Infected 51Cr-Labeled Target Cells after Incubation 
with Spleen and Lymph Node Cells  from  Virus Carriers or from Normal Mice 
Origin of lymphoid cells  Mouse  no.  Release  of 51Cr  Mean 4- SD  CI 
Virus carriers 
Normal mice 
cpm* 
1  3,012 
2  2,863 
3  2,730 
4  2,853 
5  2,892 
6  2,770 
1  2,936 
2  2,865 
3  2,884 
4  2,737 
5  2,849 
6  2,989 
3,015  4-  79  0 
3,032  4-  31  0 
* The cells from each mouse were examined in triplicate, and the mean value is shown. 
TABLE  IV 
The  Cytotoxic Effect of Acutely Sensitized Lymphocytes upon  LCM  Virus-Infected L  Cells 
Preincubated with Normal Mouse Serum or Serum from  Virus Carriers 
Source of serum  Serum pool*  Release of 51Cr  CI 
cpm 
Normal mice  I  13,888  4-  838  75.3 
Virus carriers  I  13,178  4-  624  68.7 
Normal mice  II  10,940  4-  278  49.2 
Virus carriers  II  11,223  4-  264  51.7 
Normal mice  III  37,073  4-  1,530  45.9 
Virus carriers  III  38,049  4-  1,320  49.2 
* Each pool consisted of serum from about 15 mice. 1520  I~fMUNITY  TO  LYMPtIOCYTIC  CHORIOMENINGITIS  VIRUS 
can influence nonsensitized cells (14). In order to elucidate whether such factors 
play a  role in the cytotoxic  test system employed in the experiments described 
above, a  series of experiments was carried out to evaluate the effect of varying 
numbers  of sensitized lymphocytes. 
In order to keep the total number of lymphoid cells constant throughout the experiments, 
mixtures of sensitized and nonsensitized lymphocytes were employed. The sensitized lymphoid 
cells were prepared from adult C3H mice inoculated i.p. with 103 LDs0 LCM virus 9 days 
earlier. The nonsensitized cells were from normal mice of the same strain, age, and sex.  The 
mixtures for the experiments were all suspensions containing increasing numbers of sensitized 
cells and decreasing numbers of nonsensitized cells.  Three experiments were carried out, and 
in each,  11  lymphocyte mixtures containing from 0  to  100.% sensitized cells were  assayed 
simultaneously for eytotoxic activity against LCM virus-infected target cells.  The final ratio 
between lymphocytes and target cells was 25:1 in exps.  I  and II, and 15:1 in exp. III. 
The  results  from  all  three  experiments  were  very  similar  and  the  data  are 
recorded  in  Fig.  5  and Table V.  In  the figure  the  CIs  are  plotted  against  the 
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FIG. 5.  The cytotoxic effect of different lymphocyte mixtures containing increasing per- 
centages of sensitized cells.  The mixtures were prepared from spleen and lymph node cells 
from C3H mice infected 9 days earlier and from uninfected animals. The ratio between target 
cells and lymphocytes was 1:25. 
TABLE  V 
The Cytoloxic Effect of Lymphoid Cell Suspensions  ~4th an Increasing  Ratio between 
Sens#ized  and Nonsensilized  Cells 
Cytotoxicity expressed in CI 
Exp.  Percentage of sensitized cellsin the suspension 
10  20  30  40  50  60  70  80  90  I00 
I  29  49  60  67  75  79  80  78  81  79 
II  7  24  39  63  78  89  99  99  100  100 
III*  5  11  21  26  31  36  40  47  51  65 
* This experiment was carried out with a  ratio between lymphocytes and target cells of 
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percentage of sensitized cells in the reaction mixtures. It is seen that there is a 
direct linear relationship between these variables, indicating that the cytotoxic 
effect is caused by a direct cell-to-cell reaction. Moreover, in the first two ex- 
periments a  mixture containing  about 60%  sensitized cells  (i.e.,  15  sensitized 
lymphocytes per target cell)  was sufficient to cause a  maximal effect. In the 
third experiment, however, in which a final ratio of 15 : 1 was used, the maximal 
effect was only just reached, if attained at all. 
DISCUSSION 
The  role of the  cell-mediated immune reactions in  the pathogenesis  of the 
LCM virus infection in mice is a very intriguing problem. This is mainly due to 
the fact that it has only recently been possible to demonstrate cell-mediated 
immune reactions to the LCM virus in vitro, and methods for quantitative in 
vitro measures have not been available. Such a method has been developed in 
this laboratory. With  the technique described it has been possible to demon- 
strate the time-course for the cell-mediated immunity during the acute infec- 
tion in mice. It was very striking that this cell-mediated immunity to the virus 
followed a course that was similar to the immune responses seen in transplanta- 
tion immunity experiments (15,  16).  In both cases, there is a distinct maximal 
effect on about the 9th day, followed by a relatively steep decrease to a very low 
level. The time-course of the D-type hypersensitivity to  the LCM virus has 
also been measured in vivo, using the footpad method, by Tosolini and Mires 
(2). Their results roughly agree with ours. This indicates that the data obtained 
in  the  in  vitro  test for the  viral cell-mediated immunity portray the  events 
which have taken place in the mouse. 
As pointed out by Volkert and Lundstedt (1), many experimental data have 
previously  been  presented  supporting  the  assumption  that  it  is  the  cell- 
mediated inmmne reaction  which  eliminates the virus during  an acute LCM 
virus infection. In this paper (Figs.  1 and 2), it is clearly seen that there is a 
much closer parallelism between  the blood virus titers  and  the cell-mediated 
immunity than between the virus titers and the development of complement- 
fixing antibodies. With  a  delay of about 3  days,  the rise and fall of the cell- 
mediated immunity closely follow the virus titer curve, whereas the antibodies 
begin to appear so late that by that time the main part of the virus has already 
been eliminated from the blood. These new data therefore add further support 
to the view that it is the cell-mediated immunity which is the most important 
factor in virus elimination. 
Experimental data have also been presented  (1, 17)  indicating that the cell- 
mediated immunity operates not only during the acute phase of the infection, 
but that it is also the main factor in keeping an LCM infection on its latent state. 
Such latent infections very often develop after an ordinary acute LCM virus 
infection in adult mice, and the animals will usually carry the occult virus for 
life (6). To keep this virus in check, it would be expected, therefore, that the 
cell-mediated immunity would  continue  to operate  at  a  high  rate for a  long 1522  IMMUNITY  TO  LYMPHOCYTIC  CHORIOMENINGITIS VIRUS 
time  after  the  primary infection.  Moreover,  the  persistance  of virus  should 
cause a  long-lasting antigenic stimulus which  should  be sufficient to keep the 
immunity at a high level. In spite of this our data apparently indicate that the 
cell-mediated immunity to the LCM virus is of short duration. This is rather 
surprising.  On the other hand it resembles the situation  seen in mice after an 
intravenous stimulation with sheep red blood cells.  In these animals there is a 
short  lag phase,  after  which  the  number  of  antibody-producing  cells  in  the 
spleen increases exponentially for 2-3 days and then declines to a low level (18). 
Why and in what way the immunologically active cells disappear is not known, 
but they may either have a short life-span, be inactivated by inhibitors of some 
kind, or perhaps just migrate out of the spleen and the lymph nodes. With re- 
gard to the last possibility, Tosolini and Mims' experiments, mentioned above, 
strongly indicate  that  even in  the  entire  animal  the  cell-mediated  immunity 
(expressed as D-type hypersensitivity) disappears shortly after the peak of the 
LCM viral infection. The disappearance of the active cells seems, therefore, to 
be more than a local phenomenon. 
The importance of the cell-mediated immunity for the viral elimination which 
takes place during an adoptive immunization of neonatally infected virus car- 
riers  is uncertain.  In  these  cases,  no  significant  time difference between  the 
humoral and the cell-mediated immune responses could be demonstrated. More- 
over, the intensity of the cell-mediated immunity was markedly lower than the 
response during  the  acute  infection,  whereas  the  antibody  titers  could  reach 
values  about  100  times  as  high  as  those  obtained  in  acutely  infected  mice. 
When these  results  are considered  together with  the fact that  adoptively im- 
nmnized  virus  carrier mice  also  develop  antibodies with  a  strong  virus-neu- 
tralizing capacity, a phenomenon never seen in mice acutely infected with the 
LCM virus, we are inclined  to believe the humoral immunity to be the most 
important factor in the elimination of the virus in adoptively immunized mice. 
For many years it has been widely accepted that a state of tolerance to the 
LCM virus could be established  in  mice. However, Oldstone  and Dixon  (19) 
have recently published data indicating that some degree of humoral as well as 
cell-mediated immunity may be present in the apparently tolerant mice. More- 
over,  Allison  (personal  communication)  has suggested  that  in  such  mice  en- 
hancing antibodies may obscure the presence of cell-mediated immunity. In our 
experiments these  hypotheses were put  to a  direct  test.  The experiments re- 
vealed, however, that the cytotoxic effect of lymphocytes from virus carriers did 
not exceed the effect of lymphocytes from normal mice and, moreover, serum 
from virus carrier mice was not able to protect target cells from the lyric effect 
of  activated  lymphocytes from acutely  infected  mice.  Thus  our experiments 
failed to produce any evidence indicating either cell-mediated immunity to the 
virus, or the presence of enhancing antibodies in the virus carrier mice. How- 
ever, as might be the case in ordinary adult mice a long time after an acute in- 
fection, the active cells,  if present in virus carriers, might not be located in the OLE  MARKER  AND  MOGENS  VOLKERT  1523 
organs  used  for cell preparations.  Furthermore  the  enhancing  antibodies,  if 
present in the serum from virus carriers, might not be able to cover all the virus- 
induced cell surface antigens which are continuously produced during the  18 
h duration of the in vitro cytotoxic test. However, because of the fact that pre- 
liminary experiments carried out in this laboratory have revealed that the tar- 
get cells were not protected even when the serum from carrier mice was present 
during the entire cytotoxic assay, this assumption does not seem very likely. We 
can only conclude that our results do not completely eliminate the possibility of 
the presence of cell-mediated immunity in virus carriers, but they do not, on the 
other hand, provide any support for the hypothesis. 
In recent years controversial hypotheses concerning the basic mechanism of 
the in vitro cytotoxic reaction have appeared. It has been claimed that a soluble 
factor released from sensitized lylnphocytes after contact with antigen might be 
the mediator of the cytolytic reaction (20, 21). Moreover, Oldstone and Dixon 
have demonstrated the existence of  a  soluble cytolytic factor released  after 
several days of incubation of immune lymphoid cells with the LCM virus (22). 
In Oldstone and Dixon's experiments, the release of the factor seems to be im- 
munologically specific, but once released the cytolytic effect seems to be non- 
specific. 
Other investigators have searched for soluble factors which might play a role 
in the lymphoid cytotoxic reaction, but have failed to demonstrate any such 
factors, and it seems that the majority of the workers concerned are inclined t~ 
believe that the cytolysis of target cells brought about by sensitized lympho- 
cytes is caused by a direct cell-to-cell contact (23, 24). The results from our dose 
response experiments reveal a direct linear relationship between the number of 
sensitized lymphocytes and the degree of cytolysis. This supports the assumption 
that a possible soluble factor taking part in this reaction cannot be of major im- 
portance. Moreover, the "one-hit kinetic" type of this curve indicates that only 
one type of lymphoid cells is necessary to bring about the destruction of a target 
cell. 
SUMMARY 
A  large amount of experimental evidence has already been presented indi- 
cating the great importance of the cell-mediated immunity in the pathogenesis 
of theLCM virus infection in mice. In this laboratory a method which makes it 
possible to measure this cellular immunity quantitatively in vitro has been de- 
veloped. The method is based on the determination of the radioisotope released 
after the interaction between specifically sensitized lymphocytes and syngeneic 
1Cr-labeled LCM virus-infected target cells. By using this technique the  time- 
course of the cell-mediated immunity has been  established in acutely infected 
mice and  in  virus  carriers  adoptively immunized  with  syngeneic  sensitized 
lymphocytes. Lymphocytes from acutely infected mice showed a strong lysing 
effect on the target cells, with a sharp maximum at about the 9th day after in- 1524  IM2VIUNITY  TO  LYMPHOCYTIC  CIYORIOMENINGIT1S  VIRUS 
fection. The cell-mediated immunity in adoptively immunized virus carrier mice 
showed the same time-course, but in these animals the lytic effect of the lym- 
phoid cells was considerably less pronounced. Lymphocytes from untreated vi- 
rus carriers did not, however, have any effect on the target cells, and in these 
animals  it  was  not  possible  to  demonstrate  any  evidence of enhancing anti- 
bodies. In experiments  employing serial  dilutions of sensitized 1}~nphocytes in 
normal cells a direct linear relationship between the number of sensitized lym- 
phocytes and target cell destruction was found. These experiments seem to in- 
dicate that the underlying mechanism in the cytotoxic reaction is a direct cell- 
to-cell interaction. 
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